Oncology Business Management | Specialty

City of Hope Orange County’s Edward S. Kim, M.D., M.B.A., Named Among the Nation’s 25 Science and Policy Leaders by Friends of Cancer Research

June 11th 2021

Preeminent oncologist Edward S. Kim, MD, MBA, has been named among the nation’s top cancer leaders by Friends of Cancer Research, a national organization dedicated to advances in science, policy, and regulations that speed lifesaving treatments to patients.

New Program Aims to Improve Diversity Among Investigators, Clinical Trial Participants

May 28th 2021

Getting the Best From Mentorship

May 26th 2021

Mentors may help in career development, personal matters, research activities, and professional growth.

Dr. Kahn on the Importance of Diverse Clinical Trial Participation in Oncology

May 26th 2021

Justine Kahn, MD, MS, discusses the importance of diverse clinical trial participation within the oncology space.

A Caregiver’s Experience Defines a Physician’s Practice

May 25th 2021

Although there are some weeks that are harder than others during my first year of fellowship, I sincerely feel that there is nothing I would rather be doing than practicing medicine.

Physician Confidence in Biosimilars Rests on Real-world Data

May 19th 2021

Providers and health care institutions want more real-world data on how patients respond to various biosimilar products, according to a varied panel of private practice, academic hospital, and group purchasing organization experts in a discussion at the Community Oncology Alliance virtual 2021 Community Oncology Conference in April.

Shortage of Cancer Care Providers in Rural Areas Affects Patient Outcomes

May 11th 2021

In the United States, a geographic mismatch exists between the number of medical oncology and radiation providers and patients needing care, with more specialists clustered in urban and metropolitan areas.

Evolving Psychosocial Care Models Step Forward as the Next Targeted Cancer Therapy

May 7th 2021

During this search for a breast cancer support system, my mother also investigated complementary therapies that peers had used to help cope with their fears, adverse effects, and feelings of helplessness.

ASCO-ACCC Piloting Test Tools to Diversify Cancer Clinical Trials

May 4th 2021

The American Society of Clinical Oncology and Association of Community Cancer Centers announced plans to test a research site assessment tool and implicit bias training program, both of which are designed to address one of the barriers to clinical trials participation: trials not routinely offered by clinicians to eligible patients.

Clinical Trial Diversity Efforts Gain Steam

May 4th 2021

Nearly 30 years after National Institutes of Health sought to increase participation of minorities in clinical trials, a demographic imbalance remains.

Pandemic Intensifies the Struggle With Burnout in Cancer Field

April 21st 2021

The COVID-19 pandemic has added another burden, with growing evidence of its negative effects on the well-being of many cancer care providers.

Telehealth Is Poised for a Post–COVID-19 Future

April 14th 2021

During the COVD-19 pandemic, the expansion of covered services for telehealth by the Centers for Medicare & Medicaid Services and private insurers has provided a safer alternative for patients and physicians.

Public Health Communication Gaps Extend to Cancer Care

April 6th 2021

In the cancer arena, COVID-19 information problems highlight the critical role of clear, honest, and effective communication with the public, patients, and their families regarding the increasing complexity of a multitude of topics related to malignant disease and its management.

On the Move: Narjust Duma Named Associate Director of the Cancer Equity Program at Dana-Farber

March 30th 2021

Narjust Duma, MD, has been named as the new associate director of the Cancer Care Equity Program at the Dana-Farber Cancer Institute, as well as an assistant professor of medicine at Harvard Medical School.

The COVID-19 Pandemic Will Have Long-Term Impact on Oncology Practices

March 29th 2021

The COVID-19 pandemic created new patient care challenges in oncology, such as how to reduce risks of virus exposure for patients who may be immunocompromised and switching from in-person visits to telemedicine.

Diversity Gap Persists for Racial and Ethnic Minorities in Oncology

March 23rd 2021

Despite many diversity initiative over the past 10 years, a lack of meaningful representation of certain racial and ethnic minorities continues in the oncology workforce.

Dr. Majhail on the Importance of Utilizing Social Media in Oncology

March 17th 2021

Navneet Majhail, MD, MS, discusses the importance of utilizing social media in oncology.

A More Simplified Health Care System is Needed to Provide Value

March 1st 2021

Although scientific advances in hematology and oncology have been extraordinary, the US health care system faces significant challenges in ensuring that patients receive high-quality, cost-effective care.

Remembering Henrietta Lacks: Progressing Clinical Cancer Research and Repairing Trust in the Medical Community

February 27th 2021

Although the research that emerged from the discovery of the HeLa cell line has helped to prevent 4.5 billion global infections and 10.3 million global deaths, the unethical and controversial nature of their discovery has raised issues with regard to privacy and consent in underrepresented patient populations.

Practices Grapple With an Aging Oncology Workforce

February 25th 2021

The COVID-19 pandemic may have stalled some physician retirements, but some experts are predicting an exodus of oncologists within the next 1 or 2 years. Practice managers are working now to mitigate the impact with both formal and informal initiatives.